Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism

被引:162
作者
Wang, Yan [1 ]
Shou, Jia-Wen [1 ]
Li, Xiao-Yang [1 ]
Zhao, Zhen-Xiong [1 ]
Fu, Jie [1 ]
He, Chi-Yu [1 ]
Feng, Ru [1 ]
Ma, Chao [1 ]
Wen, Bao-Ying [1 ]
Guo, Fang [1 ]
Yang, Xin-Yi [3 ]
Han, Yan-Xing [1 ]
Wang, Lu-Lu [1 ]
Tong, Qian [2 ]
You, Xue-Fu [3 ]
Lin, Yuan [1 ]
Kong, Wei-Jia [3 ]
Si, Shu-Yi [3 ]
Jiang, Jian-Dong [1 ,3 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China
[2] Jilin Univ, Hosp 1, Changchun 130021, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Insitute Med Biotechnol, Beijing 100050, Peoples R China
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2017年 / 70卷
基金
中国国家自然科学基金;
关键词
Berberine; Gut microbiota; Butyrate; Blood lipids and glucose; CHAIN FATTY-ACIDS; BUTYRATE-PRODUCING BACTERIA; INTESTINAL MICROBIOTA; PROTEIN-KINASE; FERMENTATION; ABSORPTION; HEALTH; INDUCTION; MECHANISM; RESPONSES;
D O I
10.1016/j.metabol.2017.02.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Berberine (BBR) clinically lowers blood lipid and glucose levels via multi-target mechanisms. One of the possible mechanisms is related to its effect on the short chain fatty acids (SCFAs) of the gut microbiota. The goal of this study is to investigate the therapeutic effect and mode of action of BBR working through SCFAs of the gut microbiota (especially, butyrate). Methods. Gas chromatography (GC) was used to detect butyrate and other SCFAs chemically. The effect of BBR on butyrate production was investigated in vitro as well as in several animal systems. Microarrays were used to analyze the composition change in the intestinal bacteria community after treatment with BBR. BBR-induced change in the energy production and gene regulation of intestinal bacteria was examined in order to elucidate the underlying molecular mechanisms. Results. We show that oral administration of BBR in animals promoted the gut microbiota to produce butyrate, which then enters the blood and reduces blood lipid and glucose levels. Incubating gut bacterial strains in vitro with BBR increased butyrate production. Orally treating animals directly with butyrate reduced blood lipid and glucose levels through a mechanism different from that of BBR. Intraperitoneal BBR administration did not increase butyrate but reduced blood lipid and glucose levels, suggesting that BBR has two modes of action: the direct effect of the circulated BBR and the indirect effect working through butyrate of the gut microbiota. Pre-treating animals orally with antibiotics abolished the effect of BBR on butyrate. A mechanism study showed that BBR (given orally) modified mice intestinal bacterial composition by increasing the abundance of butyrate producing bacteria. Furthermore, BBR suppressed bacterial ATP production and NADH levels, resulting in increased butyryl-CoA and, eventually, butyrate production via upregulating phosphotransbutyrylase/butyrate kinase and butyryl-CoA:acetate-CoA transferase in bacteria. Conclusion. Promotion of butyrate (etc) production in gut microbiota might be one of the important mechanisms of BBR in regulating energy metabolism. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:72 / 84
页数:13
相关论文
共 62 条
[1]   Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species [J].
Atarashi, Koji ;
Tanoue, Takeshi ;
Shima, Tatsuichiro ;
Imaoka, Akemi ;
Kuwahara, Tomomi ;
Momose, Yoshika ;
Cheng, Genhong ;
Yamasaki, Sho ;
Saito, Takashi ;
Ohba, Yusuke ;
Taniguchi, Tadatsugu ;
Takeda, Kiyoshi ;
Hori, Shohei ;
Ivanov, Ivaylo I. ;
Umesaki, Yoshinori ;
Itoh, Kikuji ;
Honda, Kenya .
SCIENCE, 2011, 331 (6015) :337-341
[2]   Berberine inhibits PTP1B activity and mimics insulin action [J].
Chen, Chunhua ;
Zhang, Yuebo ;
Huang, Cheng .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 397 (03) :543-547
[3]   8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models [J].
Cheng, Zhe ;
Chen, An-Feng ;
Wu, Fang ;
Sheng, Li ;
Zhang, Han-Kun ;
Gu, Min ;
Li, Yuan-Yuan ;
Zhang, Li-Na ;
Hu, Li-Hong ;
Li, Jing-Ya ;
Li, Jia .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (16) :5915-5924
[4]   The Impact of the Gut Microbiota on Human Health: An Integrative View [J].
Clemente, Jose C. ;
Ursell, Luke K. ;
Parfrey, Laura Wegener ;
Knight, Rob .
CELL, 2012, 148 (06) :1258-1270
[5]   Effects of acetate and butyrate during glycerol fermentation by Clostridium butyricum [J].
Colin, T ;
Bories, A ;
Lavigne, C ;
Moulin, G .
CURRENT MICROBIOLOGY, 2001, 43 (04) :238-243
[6]   Effects of berberine on lipid profile in subjects with low cardiovascular risk [J].
Derosa, Giuseppe ;
D'Angelo, Angela ;
Bonaventura, Aldo ;
Bianchi, Lucio ;
Romano, Davide ;
Maffioli, Pamela .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (04) :475-482
[7]   The Effects of Berberine on Blood Lipids: A Systemic Review and Meta-Analysis of Randomized Controlled Trials [J].
Dong, Hui ;
Zhao, Yan ;
Zhao, Li ;
Lu, Fuer .
PLANTA MEDICA, 2013, 79 (06) :437-446
[8]   Absorption, distribution and mechanism of action of SYSADOAS [J].
du Souich, Patrick .
PHARMACOLOGY & THERAPEUTICS, 2014, 142 (03) :362-374
[9]   Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production [J].
Endesfelder, David ;
Engel, Marion ;
Davis-Richardson, Austin G. ;
Ardissone, Alexandria N. ;
Achenbach, Peter ;
Hummel, Sandra ;
Winkler, Christiane ;
Atkinson, Mark ;
Schatz, Desmond ;
Triplett, Eric ;
Ziegler, Anette-Gabriele ;
Castell, Wolfgang Zu .
MICROBIOME, 2016, 4
[10]   Transforming berberine into its intestine-absorbable form by the gut microbiota [J].
Feng, Ru ;
Shou, Jia-Wen ;
Zhao, Zhen-Xiong ;
He, Chi-Yu ;
Ma, Chao ;
Huang, Min ;
Fu, Jie ;
Tan, Xiang-Shan ;
Li, Xiao-Yang ;
Wen, Bao-Ying ;
Chen, Xi ;
Yang, Xin-Yi ;
Ren, Gang ;
Lin, Yuan ;
Chen, Yangchao ;
You, Xue-Fu ;
Wang, Yan ;
Jiang, Jian-Dong .
SCIENTIFIC REPORTS, 2015, 5